These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 21862264)
1. Anti-microbial and therapeutic effects of modified Burow's solution on refractory otorrhea. Jinnouchi O; Kuwahara T; Ishida S; Okano Y; Kasei Y; Kunitomo K; Takeda N Auris Nasus Larynx; 2012 Aug; 39(4):374-7. PubMed ID: 21862264 [TBL] [Abstract][Full Text] [Related]
2. [Effects of Burow's solution as an ear drop on Intractable chronic suppurative diseases of the external ear canal and middle ear]. Terayama Y; Takizawa M; Gotouda H; Sutou S; Kashiwamura M Nihon Jibiinkoka Gakkai Kaiho; 2003 Jan; 106(1):28-33. PubMed ID: 12647321 [TBL] [Abstract][Full Text] [Related]
3. The efficacy of Burow's solution as an ear preparation for the treatment of chronic ear infections. Kashiwamura M; Chida E; Matsumura M; Nakamaru Y; Suda N; Terayama Y; Fukuda S Otol Neurotol; 2004 Jan; 25(1):9-13. PubMed ID: 14724484 [TBL] [Abstract][Full Text] [Related]
4. Use of a modified Burow's solution to treat canine otitis externa: A randomised comparative clinical study. Sadeghi S; Kamrani A; Kuc U; Polissar N; Selukar S; Sadeghi S Vet Rec; 2022 Feb; 190(3):e503. PubMed ID: 34091924 [TBL] [Abstract][Full Text] [Related]
5. Burow's solution in the treatment of active mucosal chronic suppurative otitis media: determining an effective dilution. Thorp MA; Gardiner IB; Prescott CA J Laryngol Otol; 2000 Jun; 114(6):432-6. PubMed ID: 10962675 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the Stability and Antibacterial Activity of Burow's and Neo-Burow's Solutions was Prepared Using Different Methods]. Kinoshita M; Yamagishi R; Iizaka Y; Takigawa M; Anzai Y; Urano A; Hirose K; Hanawa T; Tanaka H Yakugaku Zasshi; 2024; 144(9):887-896. PubMed ID: 39218656 [TBL] [Abstract][Full Text] [Related]
8. [Pharmaceutical and pharmacological evaluation of Burow's solution (aluminum acetate solution), hospital preparation, and development of its rapid preparation method]. Ishibashi Y; Murakami T; Yumoto R; Sakai M; Shintani H; Itaha H; Kanbe M; Masuda S; Yajin K; Kihira K; Takano M Yakugaku Zasshi; 2004 Nov; 124(11):833-40. PubMed ID: 15516810 [TBL] [Abstract][Full Text] [Related]
9. The antibacterial activity of acetic acid and Burow's solution as topical otological preparations. Thorp MA; Kruger J; Oliver S; Nilssen EL; Prescott CA J Laryngol Otol; 1998 Oct; 112(10):925-8. PubMed ID: 10211213 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial effects of Burow's solution on Staphylococcus aureus and Pseudomonas aeruginosa. Hyo Y; Yamada S; Ishimatsu M; Fukutsuji K; Harada T Med Mol Morphol; 2012 Jun; 45(2):66-71. PubMed ID: 22718290 [TBL] [Abstract][Full Text] [Related]
11. Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa. Sumitsawan Y; Tharavichitkul P; Prawatmuang W; Ingsuwan B; Sriburi P J Med Assoc Thai; 1995 Sep; 78(9):455-9. PubMed ID: 7561571 [TBL] [Abstract][Full Text] [Related]
12. Comparative antibacterial activity of topical antiseptic eardrops against methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa. Youn CK; Jang SJ; Jo ER; Choi JA; Sim JH; Cho SI Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():80-3. PubMed ID: 27240501 [TBL] [Abstract][Full Text] [Related]
13. The appropriate medical management of methicillin-resistant Staphylococcus aureus in chronic suppurative otitis media. Choi HG; Park KH; Park SN; Jun BC; Lee DH; Yeo SW Acta Otolaryngol; 2010; 130(1):42-6. PubMed ID: 19424918 [TBL] [Abstract][Full Text] [Related]
14. The development of antibiotic resistant organisms with the use of ototopical medications. Weber PC; Roland PS; Hannley M; Friedman R; Manolidis S; Matz G; Owens F; Rybak L; Stewart MG Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S89-94. PubMed ID: 15054367 [TBL] [Abstract][Full Text] [Related]
15. Microbiological profile with antibiotic sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children. Madana J; Yolmo D; Kalaiarasi R; Gopalakrishnan S; Sujatha S Int J Pediatr Otorhinolaryngol; 2011 Sep; 75(9):1104-8. PubMed ID: 21715027 [TBL] [Abstract][Full Text] [Related]
16. The treatment of chronic suppurative otitis media and otitis externa with 0.3 per cent ofloxacin otic solution: a clinico-microbiological study. Supiyaphun P; Tonsakulrungruang K; Chochaipanichnon L; Chongtateong A; Samart Y J Med Assoc Thai; 1995 Jan; 78(1):18-21. PubMed ID: 7622972 [TBL] [Abstract][Full Text] [Related]
17. Preoperative, intraoperative, and postoperative results of bacterial culture from patients with chronic suppurative otitis media. Ahn JH; Kim MN; Suk YA; Moon BJ Otol Neurotol; 2012 Jan; 33(1):54-9. PubMed ID: 22143302 [TBL] [Abstract][Full Text] [Related]
18. Malignant external otitis: treatment with prolonged usage of antibiotics and Burow's solution. Shimizu T; Ishinaga H; Seno S; Majima Y Auris Nasus Larynx; 2005 Dec; 32(4):403-6. PubMed ID: 16026955 [TBL] [Abstract][Full Text] [Related]
20. Determination of the lowest dilution of aluminium acetate solution able to inhibit in vitro growth of organisms commonly found in chronic suppurative otitis media. Thorp MA; Oliver SP; Kruger J; Prescott CA J Laryngol Otol; 2000 Nov; 114(11):830-1. PubMed ID: 11144829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]